← Leaderboards
Jonathan David Brown
Brigham And Women'S Hospital
$6,203,711
Attributed
$6,727,751
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2011–25$2M$1.5M$1M$500K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,727,751 · 4
By mechanism
R01$6,049,451 · 3
K08$678,300 · 1
Top collaborators
- Amanda C Doran1 shared
- Meenakshi Swaminathan Madhur1 shared
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Andrew H Lichtman$12,069,332
- Guo-Ping Shi$19,551,120
- Gail Kurr Adler$16,472,973
- Frank M Sacks$39,642,820
- Guillermo Garcia-Cardena$4,874,766
Others in their field
Top investigators on “United States National Institutes Of Health”
- Leonard Freedman · Leidos Biomedical Research, Inc.$816,847,401
- Sonia M Thomas · Research Triangle Institute$701,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$642,073,624
- Bambra Strokes · Ppd Development Lp$526,656,217
- Lawrence Corey · Fred Hutchinson Cancer Center$513,687,120
- Tracy L Nolen · Research Triangle Institute$474,487,152
Research focus
United States National Institutes Of HealthCellsAtherosclerosisBlood VesselsMolecularResponseInflammationPathway InteractionsGene ExpressionCessation Of LifeInsightLoss Of FunctionProductionIn VivoMortalityHepaticMouse ModelDesignLipidsFunctional DisorderGenesGenetic TranscriptionMissionAutomobile Driving
Grant awards (16)
Hypertension-associated Trained Immunity in Myeloid Cells is a Determinant of Atherosclerosis$786,060
R01 · FY2025 · HL
Gene Therapy in Hutchinson-Gilford Progeria Syndrome$724,153
R01 · FY2025 · HL · contact PI
Gene Therapy in Hutchinson-Gilford Progeria Syndrome$709,670
R01 · FY2024 · HL · contact PI
Gene Therapy in Hutchinson-Gilford Progeria Syndrome$724,153
R01 · FY2023 · HL · contact PI
Elucidating the chromatin-dependent mechanisms governing chronic inflammatory activation of endothelial cells in atherosclerosis.$586,378
R01 · FY2023 · HL · contact PI
Gene Therapy in Hutchinson-Gilford Progeria Syndrome$742,403
R01 · FY2022 · HL · contact PI
Elucidating the chromatin-dependent mechanisms governing chronic inflammatory activation of endothelial cells in atherosclerosis.$586,378
R01 · FY2022 · HL · contact PI
Elucidating the chromatin-dependent mechanisms governing chronic inflammatory activation of endothelial cells in atherosclerosis.$586,378
R01 · FY2021 · HL · contact PI
Elucidating the chromatin-dependent mechanisms governing chronic inflammatory activation of endothelial cells in atherosclerosis.$603,878
R01 · FY2020 · HL · contact PI
Hepatic Lipase, PPAR-delta and Fatty Acid Metabolism$73,209
K08 · FY2015 · HL · contact PI
Hepatic Lipase, PPAR-delta and Fatty Acid Metabolism$53,135
K08 · FY2015 · HL · contact PI
Hepatic Lipase, PPAR-delta and Fatty Acid Metabolism$9,316
K08 · FY2015 · HL · contact PI
Hepatic Lipase, PPAR-delta and Fatty Acid Metabolism$135,660
K08 · FY2014 · HL · contact PI
Hepatic Lipase, PPAR-delta and Fatty Acid Metabolism$135,660
K08 · FY2013 · HL · contact PI
Hepatic Lipase, PPAR-delta and Fatty Acid Metabolism$135,660
K08 · FY2012 · HL · contact PI
Hepatic Lipase, PPAR-delta and Fatty Acid Metabolism$135,660
K08 · FY2011 · HL · contact PI